Trade, health and profit in a time of pandemic
Every aspect of global health policy must now be reconsidered from the perspective of AP (After the Pandemic), although the pandemic of course is still with us. One of the pandemic’s early lessons was the fragility of a profit-oriented system for vaccine development. Before the pandemic, there were only four major transnational vaccine producers, … Continued